Sign in to continue:

Thursday, March 5th, 2026

China Longevity Group Announces Board Meeting to Approve 2025 Final Results and Dividend on March 27, 2026 1

China Longevity Group Schedules Board Meeting to Consider FY2025 Final Results and Dividend

China Longevity Group Announces Board Meeting to Review FY2025 Final Results and Possible Dividend

Key Highlights for Investors:

  • Board Meeting Date: The Board of Directors of China Longevity Group Company Limited (Stock Code: 1863) has scheduled a crucial meeting for Friday, 27 March 2026 at 3:00 pm.
  • Agenda: The primary items to be discussed include:
    • Reviewing and approving the final results announcement for the financial year ended 31 December 2025.
    • Authorizing the publication of the results for investor and market information.
    • Considering the payment of a final dividend, if any, to shareholders.

Potential Share Price Impact

The upcoming board meeting is significant for shareholders and potential investors, as the final results announcement and any decision regarding the distribution of a final dividend are both potentially price-sensitive events. Such disclosures typically influence investor sentiment and may lead to share price volatility depending on the results and the dividend policy adopted.

Investors should pay close attention to the publication of the company’s final results for FY2025 and any announcement related to dividend distribution, as these will provide insight into China Longevity Group’s financial health, profitability, and management’s outlook for capital returns. Any positive surprises, such as higher-than-expected earnings or an increased dividend, may support the share price, while negative results could have the opposite effect.

Board Composition

The board is currently comprised of:

  • Executive Directors: Mr. Liu Jun (Chairman and Executive Director), Mr. Jiang Shisheng, and Mr. Gao Juwen
  • Independent Non-Executive Directors: Mr. Lau Chun Pong, Mr. Lu Jiayu, and Ms. Jiang Ping

This balanced structure is designed to ensure robust governance and oversight in the decision-making process, especially concerning matters that have direct implications for shareholder value.

Conclusion

The scheduled board meeting and its agenda items are material events for China Longevity Group shareholders. Investors are advised to monitor the outcome of the meeting for updates on the company’s performance and dividend decisions, as these could materially impact the company’s share price.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research or consult a professional adviser before making investment decisions.


View CHI LONGEVITY Historical chart here



BlackRock, Inc. Share Dealings Disclosure in ENN Energy Holdings Ltd During Privatisation Scheme – February 2026 1

BlackRock, Inc. Increases Stake in ENN Energy Holdings Amid Privatisation Scheme BlackRock, Inc. Increases Stake in ENN Energy Holdings Amid Privatisation Scheme Key Highlights Date of disclosure: 28 February 2026 Subject: Privatisation by way...

HSBC Announces Dame Carolyn Fairbairn as Incoming Chair of HSBC UK Bank plc, Strengthening UK Leadership and Governance 2

HSBC Holdings plc – Director Succession and Subsidiary Board Update HSBC Holdings plc Announces Director Succession for Key Subsidiary Board Role Key Points for Investors Dame Clara Furse, after 9 years as non-executive Chair...

China Tower Corporation Limited Announces Board Meeting to Approve 2025 Financial Results and Dividend Consideration 1

China Tower Corporation Limited Announces Board Meeting to Approve 2025 Financial Results and Consider Final Dividend China Tower Corporation Limited Schedules Key Board Meeting for 2025 Financial Results and Dividend Decision China Tower Corporation...

   Ad